TY - CHAP
T1 - Metabolomics Analysis of Blood, Urine, and Saliva Samples Based on Capillary Electrophoresis–Mass Spectrometry
AU - Sugimoto, Masahiro
AU - Aizawa, Yumi
N1 - Funding Information:
This research was funded by grants from JSPS KAKENHI (grant number 20B205).
Publisher Copyright:
© 2023, The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2023
Y1 - 2023
N2 - Capillary electrophoresis–mass spectrometry (CE–MS) is an ideal method for analyzing various metabolites in biological samples. CE–MS can simultaneously identify and quantify hundreds of charged metabolites using only two acquisition methods for positively and negatively charged metabolites. Furthermore, CE–MS is commonly used for analyzing biological samples to understand the pathology of diseases at the metabolic level and biofluid samples, such as blood and urine, to explore biomarkers. Here, we introduce a protocol that delineates the handling of clinical samples to ensure that the CE–MS analysis yields reproducible quantified data. We have focused on sample collection, storage, processing, and measurement. Although the implementation of rigorous standard operating protocols is preferred for enhancing the quality of the samples, various limitations in an actual clinical setting make it difficult to adhere to strict rules. Therefore, the effect of each process on the quantified metabolites needs to be evaluated to design a protocol with acceptable tolerances. Furthermore, quality controls and assessments to handle clinical samples are introduced.
AB - Capillary electrophoresis–mass spectrometry (CE–MS) is an ideal method for analyzing various metabolites in biological samples. CE–MS can simultaneously identify and quantify hundreds of charged metabolites using only two acquisition methods for positively and negatively charged metabolites. Furthermore, CE–MS is commonly used for analyzing biological samples to understand the pathology of diseases at the metabolic level and biofluid samples, such as blood and urine, to explore biomarkers. Here, we introduce a protocol that delineates the handling of clinical samples to ensure that the CE–MS analysis yields reproducible quantified data. We have focused on sample collection, storage, processing, and measurement. Although the implementation of rigorous standard operating protocols is preferred for enhancing the quality of the samples, various limitations in an actual clinical setting make it difficult to adhere to strict rules. Therefore, the effect of each process on the quantified metabolites needs to be evaluated to design a protocol with acceptable tolerances. Furthermore, quality controls and assessments to handle clinical samples are introduced.
KW - Biofluid
KW - Capillary electrophoresis–mass spectrometry
KW - Clinical samples
UR - http://www.scopus.com/inward/record.url?scp=85138459708&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85138459708&partnerID=8YFLogxK
U2 - 10.1007/978-1-0716-2699-3_8
DO - 10.1007/978-1-0716-2699-3_8
M3 - Chapter
C2 - 36152152
AN - SCOPUS:85138459708
T3 - Methods in Molecular Biology
SP - 83
EP - 94
BT - Methods in Molecular Biology
PB - Humana Press Inc.
ER -